|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Fabry Disease | |||||
| 2 | More general conditions related to this trial | ||||
| Brain Diseases | |||||
| Brain Diseases, Metabolic | |||||
| Brain Diseases, Metabolic, Inborn | |||||
| Central Nervous System Diseases | |||||
| Genetic Diseases, Inborn | |||||
| Genetic Diseases, X-Linked | |||||
| Lipid Metabolism Disorders | |||||
| Lipid Metabolism, Inborn Errors | |||||
| Lipidoses | |||||
| Lysosomal Storage Diseases | |||||
| Lysosomal Storage Diseases, Nervous System | |||||
| Metabolic Diseases | |||||
| Metabolism, Inborn Errors | |||||
| Nervous System Diseases | |||||
| Sphingolipidoses | |||||
| 3 | Interventions listed in this trial | ||||
| Fabrazyme (agalsidase beta) | |||||
| 4 | Sponsors listed in this trial | ||||
| Genzyme | |||||